Canada markets closed

Chimeric Therapeutics Limited (CHM.AX)

ASX - ASX Delayed Price. Currency in AUD
Add to watchlist
0.0190+0.0010 (+5.56%)
As of 10:10AM AEST. Market open.
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-06-30
2022-06-30
2021-06-30
Operating Expenses
Research Development
5,174
13,475
5,174
3,778
Selling General and Administrative
10,201
11,924
9,138
6,168
Total Operating Expenses
17,190
29,487
17,190
15,691
Operating Income or Loss
-17,190
-29,487
-17,190
-15,691
Interest Expense
640.127
773.845
640.127
5.877
Total Other Income/Expenses Net
2,082
4,826
2,082
-263.79
Income Before Tax
-15,735
-25,408
-15,735
-15,114
Income Tax Expense
163.72
92.82
163.72
0
Income from Continuing Operations
-15,898
-25,500
-15,898
-15,114
Net Income
-15,898
-25,500
-15,898
-15,114
Net Income available to common shareholders
-15,898
-25,500
-15,898
-15,114
Basic EPS
-0.06
-0.06
-0.04
-0.08
Diluted EPS
-0.06
-0.06
-0.04
-0.08
Basic Average Shares
433,245
433,245
359,932
188,717
Diluted Average Shares
433,245
433,245
359,932
188,717